학술논문
Temporal Characteristics of Adverse Events of Tivozanib and Sorafenib in Previously Treated Kidney Cancer
Document Type
Article
Author
Source
In Clinical Genitourinary Cancer December 2022 20(6):553-557
Subject
Language
ISSN
1558-7673